{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "neonatal encephalitis , there are few or almost no effective\n\nclinical treatment against flaviviruses or enteroviruses . For\n\nexample , patients suffering from serious flavivirus or entero\n\nvirus infection may only receive supportive care including\n\nOH\n\nadministration with intravenous fluids , hospitalization ,\n\nrespiratory support , and prevention of secondary infections .\n\nwherein the flavivirus is Japanese encephalitis virus , Zika\n\nvirus or Dengue virus .\n\n[ 0004 ] There is currently a lack of effective remedy in\n\n[ 0008 ]\n\nIn a third aspect , the present invention relates to a\n\ntreating RNA virus infection particularly caused by flavivi\n\nmethod of inhibiting the entry of an enterovirus and / or a\n\nruses and enteroviruses .\n\nlentivirus into host cells , comprising contacting the host\n\ncells with an effective amount of berbamine or its analogue\n\n[ 0005 ] Accordingly , there remains a strong need for novel\n\nas described above .\n\ncompounds which are useful in the prevention or treatment\n\n[ 0009 ]\n\nIn a fourth aspect , the present invention relates to\n\nof RNA viral infection particularly flavivirus infection .\n\nuse of berbamine or its analogue in prevention or treatment\n\nof a RNA virus infection , particularly but not exclusively a\n\nSUMMARY OF THE INVENTION\n\nflavivirus infection , an enterovirus infection or a lentivirus\n\ninfection .\n\n[ 0006 ]\n\nIn a first aspect , the present invention pertains to a\n\n[ 0010 ]\n\nStill further , berbamine or its analogue may be used\n\nmethod of preventing or treating a subject suffering from a\n\nin the preparation of a medicament for preventing or treating\n\nflavivirus infection by administering an effective amount of\n\na RNA virus infection , particularly but not exclusively a\n\nberbamine or its analogue to the subject , berbamine has a\n\nflavivirus infection , an enterovirus infection or a lentivirus\n\nstructure of Formula ( I ) :\n\ninfection .\n\nUS 2021/0060002 A1\n\nMar. 4, 2021", "type": "Document"}}